These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6415746

  • 1. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
    McIntyre IM, Kuhn C, Demitriou S, Fucek FR, Stanley M.
    Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
    [Abstract] [Full Text] [Related]

  • 2. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E, Friedman E.
    Eur J Pharmacol; 1981 Nov 19; 76(1):25-9. PubMed ID: 7318921
    [Abstract] [Full Text] [Related]

  • 3. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
    Rubin EH, Wooten GF.
    Psychopharmacology (Berl); 1984 Nov 19; 84(2):217-20. PubMed ID: 6438680
    [Abstract] [Full Text] [Related]

  • 4. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB, Rozitis A.
    Eur J Pharmacol; 1982 Feb 19; 78(1):113-5. PubMed ID: 7200429
    [Abstract] [Full Text] [Related]

  • 5. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C, Oblin A, Fage D, Scatton B.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):55-62. PubMed ID: 6628547
    [Abstract] [Full Text] [Related]

  • 6. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
    Tanimoto K, Maeda K, Chihara K.
    Brain Res; 1982 Aug 05; 245(1):163-6. PubMed ID: 6811103
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
    Hernandez L, Baptista T, Hoebel BG.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Aug 05; 14 Suppl():S17-35. PubMed ID: 2097671
    [Abstract] [Full Text] [Related]

  • 8. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ, Jakubovic A, Fibiger HC.
    Psychopharmacology (Berl); 1984 Aug 05; 82(4):371-7. PubMed ID: 6427831
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC, de Vries JB, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 05; 327(4):304-11. PubMed ID: 6514014
    [Abstract] [Full Text] [Related]

  • 10. Effects of prenatal cocaine exposure on haloperidol-induced increases in prolactin release and dopamine turnover in weanling, periadolescent, and adult offspring.
    Goodwin GA, Rajachandran L, Moody CA, Francis R, Kuhn CM, Spear LP.
    Neurotoxicol Teratol; 1995 Oct 05; 17(4):507-14. PubMed ID: 7565497
    [Abstract] [Full Text] [Related]

  • 11. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG, Bellows EP, Barnes DE, Lombrozo L.
    Psychopharmacology (Berl); 1990 Oct 05; 101(4):519-24. PubMed ID: 2388975
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR, Algeri S, Stramentinoli G.
    Pharmacol Res Commun; 1987 Mar 05; 19(3):231-40. PubMed ID: 3602044
    [Abstract] [Full Text] [Related]

  • 13. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J, Coviella IL, Wurtman RJ.
    Neuropharmacology; 1984 Dec 05; 23(12A):1403-6. PubMed ID: 6543245
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 15. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A, Jackson-Lewis V, Fahn S.
    Psychopharmacology (Berl); 1984 Jan 28; 82(4):330-4. PubMed ID: 6427824
    [Abstract] [Full Text] [Related]

  • 16. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH, Spaan SJ.
    J Neurochem; 1982 Mar 28; 38(3):680-6. PubMed ID: 7057187
    [Abstract] [Full Text] [Related]

  • 17. The effect of chronic lithium administration on dopamine metabolism in rat striatum.
    Hesketh JE, Nicolaou NM, Arbuthnott GW, Wright AK.
    Psychopharmacology (Berl); 1978 Mar 01; 56(2):163-6. PubMed ID: 25454
    [Abstract] [Full Text] [Related]

  • 18. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE.
    Neurosci Lett; 1991 Aug 19; 129(2):265-8. PubMed ID: 1720879
    [Abstract] [Full Text] [Related]

  • 19. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 19; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 20. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG, Roth RH.
    Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.